Table 3 The results of molecular docking.

From: Systematic pharmacology-based strategy to explore the mechanism of Semen Strychni for treatment of papillary thyroid carcinoma

Compound

Target

PDB

Libdock score

Isobrucine

PTGS2

1CVU

98.8636

Isobrucine

JUN

1JNM

94.6501

Isobrucine

1L1B

1L1B

45.0814

Isobrucine

TP53

1GZH

96.5837

Isobrucine

VEGFA

1BJ1

78.9212

Isobrucine

IL6

1ALU

76.32

Stigmasterol

PTGS2

1CVU

94.8413

Stigmasterol

JUN

1JNM

120.188

Stigmasterol

1L1B

1L1B

75.3339

Stigmasterol

TP53

1GZH

93.1243

Stigmasterol

VEGFA

1BJ1

99.6812

Stigmasterol

IL6

1ALU

75.46

(+)-Catechin

PTGS2

1CVU

71.8213

(+)-Catechin

JUN

1JNM

118.438

(+)-Catechin

1L1B

1L1B

80.9937

(+)-Catechin

TP53

1GZH

93.9245

(+)-Catechin

VEGFA

1BJ1

91.2969

(+)-Catechin

IL6

1ALU

83.85

Brucine

PTGS2

1CVU

78.9863

Brucine

JUN

1JNM

113.797

Brucine

1L1B

1L1B

92.7554

Brucine

TP53

1GZH

92.145

Brucine

VEGFA

1BJ1

94.2969

Brucine

IL6

1ALU

78.1123